World Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $201K | Sell |
2,605
-279
| -10% | -$21.5K | 0.02% | 816 |
|
|
2021
Q2 | $241K | Sell |
2,884
-221
| -7% | -$18.5K | 0.02% | 775 |
|
|
2021
Q1 | $242K | Sell |
3,105
-245
| -7% | -$19.1K | 0.02% | 782 |
|
|
2020
Q4 | $294K | Buy |
3,350
+96
| +3% | +$8.43K | 0.03% | 652 |
|
|
2020
Q3 | $248K | Hold |
3,254
| – | – | 0.03% | 642 |
|
|
2020
Q2 | $401K | Sell |
3,254
-29
| -0.9% | -$3.57K | 0.04% | 400 |
|
|
2020
Q1 | $277K | Sell |
3,283
-1,875
| -36% | -$158K | 0.02% | 631 |
|
|
2019
Q4 | $436K | Sell |
5,158
-832
| -14% | -$70.3K | 0.02% | 647 |
|
|
2019
Q3 | $404K | Buy |
5,990
+134
| +2% | +$9.04K | 0.02% | 701 |
|
|
2019
Q2 | $502K | Buy |
5,856
+3
| +0.1% | +$257 | 0.02% | 636 |
|
|
2019
Q1 | $520K | Sell |
5,853
-129
| -2% | -$11.5K | 0.03% | 625 |
|
|
2018
Q4 | $509K | Sell |
5,982
-324
| -5% | -$27.6K | 0.03% | 554 |
|
|
2018
Q3 | $611K | Buy |
6,306
+72
| +1% | +$6.98K | 0.03% | 622 |
|
|
2018
Q2 | $587K | Sell |
6,234
-155
| -2% | -$14.6K | 0.03% | 652 |
|
|
2018
Q1 | $518K | Sell |
6,389
-1,559
| -20% | -$126K | 0.02% | 746 |
|
|
2017
Q4 | $709K | Sell |
7,948
-93
| -1% | -$8.3K | 0.02% | 742 |
|
|
2017
Q3 | $748K | Buy |
8,041
+114
| +1% | +$10.6K | 0.02% | 721 |
|
|
2017
Q2 | $720K | Buy |
7,927
+218
| +3% | +$19.8K | 0.02% | 719 |
|
|
2017
Q1 | $677K | Buy |
7,709
+1,679
| +28% | +$147K | 0.02% | 725 |
|
|
2016
Q4 | $500K | Sell |
6,030
-782
| -11% | -$64.8K | 0.02% | 800 |
|
|
2016
Q3 | $630K | Buy |
6,812
+2,888
| +74% | +$267K | 0.02% | 733 |
|
|
2016
Q2 | $305K | Buy |
3,924
+492
| +14% | +$38.2K | 0.01% | 925 |
|
|
2016
Q1 | $283K | Buy |
3,432
+86
| +3% | +$7.09K | 0.01% | 936 |
|
|
2015
Q4 | $351K | Buy |
3,346
+261
| +8% | +$27.4K | 0.01% | 840 |
|
|
2015
Q3 | $325K | Sell |
3,085
-330
| -10% | -$34.8K | 0.01% | 859 |
|
|
2015
Q2 | $467K | Sell |
3,415
-1,526
| -31% | -$209K | 0.02% | 762 |
|
|
2015
Q1 | $616K | Buy |
4,941
+50
| +1% | +$6.23K | 0.02% | 753 |
|
|
2014
Q4 | $442K | Sell |
4,891
-1,706
| -26% | -$154K | 0.02% | 888 |
|
|
2014
Q3 | $476K | Sell |
6,597
-485
| -7% | -$35K | 0.01% | 893 |
|
|
2014
Q2 | $441K | Buy |
7,082
+57
| +0.8% | +$3.55K | 0.01% | 978 |
|
|
2014
Q1 | $479K | Sell |
7,025
-61
| -0.9% | -$4.16K | 0.01% | 933 |
|
|
2013
Q4 | $498K | Sell |
7,086
-3,450
| -33% | -$242K | 0.01% | 940 |
|
|
2013
Q3 | $761K | Sell |
10,536
-2,354
| -18% | -$170K | 0.02% | 816 |
|
|
2013
Q2 | $719K | Buy |
+12,890
| New | +$719K | 0.02% | 878 |
|